Science & Enterprise subscription

Follow us on Twitter

  • Evidence collected from electronic neuro-stimulation devices shows for most people the wearable systems relieve mig… https://t.co/2RsxkVvoUA
    about 19 hours ago
  • New post on Science and Enterprise: Wearable Device Shown to Relieve Migraine Pain https://t.co/mKP8iAVKCm #Science #Business
    about 19 hours ago
  • Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editi… https://t.co/uG1FkdMzJv
    about 22 hours ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy https://t.co/3tixJDiac0 #Science #Business
    about 22 hours ago
  • First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy… https://t.co/Cgw8tTAAKY
    about 2 days ago

Please share Science & Enterprise

Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial

Syringes

Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S. . . . → Read More: Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial

Late-Stage Covid-19 Vaccine Trial Underway in U.S.

Covid-19 vaccine infographic

Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes. . . . → Read More: Late-Stage Covid-19 Vaccine Trial Underway in U.S.

Engineered Mosquitoes Approved for Disease Control

Aedes aegypti mosquito

In an apparent end to a long-running dispute, authorities in the Florida Keys approved a field trial of engineered mosquitoes to control tropical diseases. . . . → Read More: Engineered Mosquitoes Approved for Disease Control

Synthetic Protein Maker Raises $91.3M in Venture Funds

Elastapure bottle

A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round. . . . → Read More: Synthetic Protein Maker Raises $91.3M in Venture Funds

Trial Testing Point-of-Care Covid-19 Diagnostic

A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour. . . . → Read More: Trial Testing Point-of-Care Covid-19 Diagnostic

Oxford Covid-19 Vaccine Trial Invokes Immune Responses

Syrine ingloved hand

Results from a clinical trial testing a Covid-19 vaccine show the vaccine invokes two types of immune responses without serious adverse effects. . . . → Read More: Oxford Covid-19 Vaccine Trial Invokes Immune Responses

Early Venture Investors Aim for Diverse Entrepreneurs

Business ideas graphic

A new venture investment company is funding start-ups at their earliest stages, with a goal of increasing support for entrepreneurs from all backgrounds. . . . → Read More: Early Venture Investors Aim for Diverse Entrepreneurs

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Start-Up Creating a Simpler, Stable Liquid Biopsy

Blood vials

A new company spun off from University of Oxford is developing a stable and sensitive blood test to detect multiple types of cancer in their early stages. . . . → Read More: Start-Up Creating a Simpler, Stable Liquid Biopsy

Depression Therapy Licensed for Online Distribution

Man with depression

A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use. . . . → Read More: Depression Therapy Licensed for Online Distribution